Long QT Interval Syndrome and Female Sex-Review and Case Report

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Congenital Long QT Syndrome (LQTS) is a genetic disorder affecting cardiac ion channels, leading to prolonged ventricular action potentials and risk of sudden cardiac death.
• Genetic screening of families is critical for identifying at-risk individuals, both symptomatic and asymptomatic.
• LQT1, LQT2, and LQT3 are the most studied forms of LQTS, each with distinct ECG morphologies, triggers, and management strategies.

Observation:

• This case report details a young woman diagnosed with LQTS, confirmed to have KCNH2 mutations via genetic analysis.
• The same KCNH2 mutation was identified in her children, highlighting the hereditary nature of the condition.
• Therapeutic adjustments were made, including beta-blocker use based on symptoms and tolerance, and implantation of a cardioverter-defibrillator, particularly during the postpartum period due to hormonal changes.

Findings:

• Phenotypic manifestations of LQTS are significantly influenced by the specific gene affected.
• Beta-blockers are the primary treatment, but alternative therapies are necessary when they are ineffective.
• Genetic confirmation of KCNH2 mutations in a patient and her children underscores the importance of family screening.

Implications:

• Timely recognition and diagnosis of LQTS are essential for initiating appropriate management and preventing adverse events.
• Personalized treatment strategies, considering genetic background and clinical presentation, are crucial for managing LQTS.
• Proactive genetic screening and management can significantly reduce the incidence of sudden cardiac death in families with congenital LQTS.